Analyst Brian Skorney works at BAIRD and is covering the Healthcare, Industrials sectors with 540 price targets and ratings documented since 2014 spanning on 30 stocks.
Brian Skorney's average stock forecast success ratio is 55.35% with an average time for price targets to be met of 177.9 days.
Most recent stock forecast was given on BIIB, Biogen Inc at 07-Jun-2023.
Analyst best performing recommendations are on RETA (REATA PHARMACEUTICALS, INC).
The best stock recommendation documented was for RETA (REATA PHARMACEUTICALS, INC) at 2/27/2023. The price target of $40 was fulfilled within 2 days with a profit of $9.15 (29.66%) receiving and performance score of 148.3.
Average potential price target upside
Currently, out of the existing stock ratings of Brian Skorney - 4 which are a Buy (80%), 1 which are a Hold (20%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
2
$1.82 (1011.11%)
5
4 years 1 months 5 days ago
2/3 (66.67%)
$-1.08 (-9.01%)
528
Hold
4
5 years 4 months ago
4/4 (100%)
$-2.13 (-24.58%)
106
Buy
5
$4.82 (2677.78%)
6
5 years 5 months 28 days ago
0/4 (0%)
$5.96 (74.71%)
Buy
10
5 years 8 months 27 days ago
0/2 (0%)
$6.87 (118.02%)
Hold
4
$3.82 (2122.22%)
5
5 years 8 months 28 days ago
6/7 (85.71%)
$1.8 (31.38%)
49
